Premium
Expanded eligibility for emerging therapies in sickle cell disease in the UK – crizanlizumab and voxelotor
Author(s) -
Vora Sona M.,
Boyd Stephen,
Denny Nicholas,
Jackson Elizabeth,
Roy Noemi B. A.,
Howard Jo,
Lugthart Sanne
Publication year - 2022
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.18059
Subject(s) - disease , medicine , intensive care medicine , business
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom